- Home
- ROIV vs ZBRA Comparison
ROIV vs ZBRA Comparison
Compare ROIV & ZBRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- ZBRA
- Stock Information
- Founded
- ROIV 2014
- ZBRA 1969
- Country
- ROIV United Kingdom
- ZBRA United States
- Employees
- ROIV 750
- ZBRA N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- ZBRA Industrial Machinery/Components
- Sector
- ROIV Health Care
- ZBRA Industrials
- Exchange
- ROIV Nasdaq
- ZBRA Nasdaq
- Market Cap
- ROIV 14.1B
- ZBRA 14.7B
- IPO Year
- ROIV N/A
- ZBRA 1991
- Fundamental
- Price
- ROIV $20.73
- ZBRA $249.16
- Analyst Decision
- ROIV Strong Buy
- ZBRA Buy
- Analyst Count
- ROIV 8
- ZBRA 7
- Target Price
- ROIV $21.19
- ZBRA $346.29
- AVG Volume (30 Days)
- ROIV 8.4M
- ZBRA 909.1K
- Earning Date
- ROIV 11-10-2025
- ZBRA 10-28-2025
- Dividend Yield
- ROIV N/A
- ZBRA N/A
- EPS Growth
- ROIV N/A
- ZBRA 34.78
- EPS
- ROIV N/A
- ZBRA 9.93
- Revenue
- ROIV $20,329,000.00
- ZBRA $5,255,000,000.00
- Revenue This Year
- ROIV N/A
- ZBRA $10.10
- Revenue Next Year
- ROIV $320.50
- ZBRA $9.79
- P/E Ratio
- ROIV N/A
- ZBRA $24.43
- Revenue Growth
- ROIV N/A
- ZBRA 12.87
- 52 Week Low
- ROIV $8.73
- ZBRA $205.73
- 52 Week High
- ROIV $21.35
- ZBRA $427.76
- Technical
- Relative Strength Index (RSI)
- ROIV 66.63
- ZBRA 43.07
- Support Level
- ROIV $19.99
- ZBRA $227.19
- Resistance Level
- ROIV $20.99
- ZBRA $264.97
- Average True Range (ATR)
- ROIV 0.74
- ZBRA 8.44
- MACD
- ROIV -0.19
- ZBRA 1.05
- Stochastic Oscillator
- ROIV 56.41
- ZBRA 53.63
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About ZBRA Zebra Technologies Corporation
Zebra Technologies is a leading provider of automatic identification and data capture technology to enterprises. Its solutions include barcode printers and scanners, mobile computers, and workflow optimization software. The firm primarily serves the retail, transportation logistics, manufacturing, and healthcare markets, designing custom solutions to improve efficiency at its customers.